The discussion on females with intermediate G6PD activity and drug-associated risk is also conflated with the notion that G6PD-deficient people are less likely to present with severe malaria symptoms, as G6PD deficiency reduces the severity of malaria, and that females with intermediate G6PD deficiency and malaria are rarely seen. This evidence concerns the gene G6PD and malaria.